With a wide choice of health supplements in the market today, we should consider some of the following points before making a purchase, especially when it involves our most valuable asset – our health.
The health product should be natural, proven to be safe for human consumption, free of side effects and supplement nutritional needs
It should be backed by a credible theory or hypothesis, i.e., there should be a clear reason why it could work and how it possibly works.
It should show benefit from a historical supportive tradition. In other words, there should be a long history of human use and a widespread recognition of the value of the ingredients.
It should be the subject of a number of clinical studies on humans and show objective evidence of its safety and efficacy with experienced practitioners in the field. The scientific references should be valid.
SWISSOATS A111® is one such supplement that meets the above criteria. Widely known as EXSATIVA, SWISSOATS A111 is a product of Acropharma Switzerland developed specially for Singapore. This section will highlight its efficacy and safety while presenting various clinical studies performed.”
Efficacy & Safety
- SWISSOATS A111® has been tested to contain NO harmful and toxic substances by the Institute of Science and Forensic Medicine in Singapore.
- It has been awarded US patent certificate no. 4,886,665.
- It has been clinically tested in Europe, USA and Singapore and has been proven to be both safe and clinically effective.
- No side effect has been reported since the product was first sold in the US in 1985.
- It has no known negative interactions with other medications during its 20 over years of use throughout the world as confirmed by the manufacturer from Switzerland.
- Oats have the distinction of being the holder of the first food-specific health claim ever approved by the United States Food and Drug Administration (FDA). The claim was approved in 1997, and reads, “Soluble fibre from oats, as part of a low saturated fat, low cholesterol diet, may reduce the risk of heart disease.
The effectiveness of SWISSOATS A111® and its ingredients has been clinically tested in Europe, USA and Singapore and has been proven to be both safe and effective.
A 6-week double-blind cross-over clinical trial was performed with men averaging 40 years of age in which the effect of SWISSOATS A111® on the static strength of 13 muscle groups was tested. Those receiving placebo did not experience significant change, while improvement was evident in 7 muscle groups of those treated with SWISSOATS A111®. Furthermore, it was found that the exercise-induced rise in blood pressure was less severe in the treated group than in the placebo group. Remarkably, it was also recorded that diastolic pressure in SWISSOATS A111® group became lower. The anaerobic power as well as endurance time increased significantly after SWISSOATS A111® treatment, while the placebo group experienced virtually no change in these parameters. No side effects were noted.
Another study was done on benign senescent forgetfulness in which 75% showed favourable improvement in memory and mental alertness after taking SWISSOATS A111®.
A study conducted at the Hungarian University of Physical Education in Budapest measured the level of testosterone excretion following the use of SWISSOATS A111®. The subjects taking SWISSOATS A111® showed significantly higher testosterone excretion both in regard to pretreatment and compared to the placebo group.
The results showed that SWISSOATS A111®:
- Increased the free testosterone levels in patients with andropausal symptoms with or without impotence.
- Improved the andropause scores better than oral testosterone (Andriol) hormone replacement therapy and this is statistically significant (p<0.05).
- Works well with patients above 40 years and this effect is possibly due to its predominant androgenic effects (increase in free and total testosterone levels and improvement in andropause scores)
- Increase in libido or desire for sex may occur with increase in free testosterone levels and was the most frequent subjective and objective observation in the study.